Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 674 - файл

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
18 Мб
Скачать
Acute Cholecystitis andEmergency Common Bile Duct Exploration
https://t.me/medicina_free
TG13: updated Tokyo guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2013;20(1):1–7. https://doi.org/10.1007/s00534- 012- 0566- y.
9. Yokoe M, Hata J, Takada T, Strasberg SM, Asbun HJ, Wakabayashi G, Kozaka K, Endo I, Deziel DJ, Miura F, Okamoto K, Hwang TL, Huang WS, Ker CG, Chen MF, Han HS, Yoon YS, Choi IS, Yoon DS, Noguchi Y, Shikata S, Ukai T, Higuchi R, Gabata T, Mori Y, Iwashita Y, Hibi T, Jagannath P, Jonas E, Liau KH, Dervenis C, Gouma DJ, Cherqui D, Belli G, Garden OJ, Giménez ME, de Santibañes E, Suzuki K, Umezawa A, Supe AN, Pitt HA, Singh H, Chan ACW, Lau WY, Teoh AYB, Honda G, Sugioka A, Asai K, Gomi H, Itoi T, Kiriyama S, Yoshida M, Mayumi T, Matsumura N, Tokumura H, Kitano S, Hirata K, Inui K, Sumiyama Y, Yamamoto M.Tokyo guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25(1):41–54. https://doi.
org/10.1002/jhbp.515.
10. Ansaloni L, Pisano M, Coccolini F, Peitzmann AB, Fingerhut A, Catena F, Agresta F, Allegri A, Bailey I, Balogh ZJ, Bendinelli C, Bif W, Bonavina L, Borzellino G, Brunetti F, Burlew CC, Camapanelli G, Campanile FC, Ceresoli M, Chiara O, Civil I, Coimbra R, De Moya M, Di Saverio S, Fraga GP, Gupta S, Kashuk J, Kelly MD, Koka V, Jeekel H, Lati R, Leppaniemi A, Maier RV, Marzi I, Moore F, Piazzalunga D, Sakakushev B, Sartelli M, Scalea T, Stahel PF, Taviloglu K, Tugnoli G, Uraneus S, Velmahos GC, Wani I, Weber DG, Viale P, Sugrue M, Ivatury R, Kluger Y, Gurusamy KS, Moore EE. 2016 WSES guidelines on acute calculous cholecystitis. World J Emerg Surg. 2016;11:25. https://doi.org/10.1186/s13017- 016- 0082- 5.
11. Pisano M, Allievi N, Gurusamy K, Borzellino G, Cimbanassi S, Boerna D, Coccolini F, Tufo A, Di Martino M, Leung J, Sartelli M, Ceresoli M, Maier RV, Poiasina E, De Angelis N, Magnone S, Fugazzola P, Paolillo C, Coimbra R, Di Saverio S, De Simone B, Weber DG, Sakakushev BE, Lucianetti A, Kirkpatrick AW, Fraga GP, Wani I, Bif WL, Chiara O, Abu­Zidan F, Moore EE, Leppäniemi A, Kluger Y, Catena F, Ansaloni L. 2020 World Society of Emergency Surgery updated guidelines for the diagnosis and treatment of acute calculus cho­lecystitis. World J Emerg Surg. 2020;15(1):61. https://doi.org/10.1186/s13017- 020- 00336- x.
12. Naidu K, Beenen E, Gananadha S, Mosse C.The yield of fever, inammatory markers and ultrasound in the diagnosis of acute cholecystitis: a validation of the 2013 Tokyo guidelines. World J Surg. 2016;40(12):2892–7. https://doi.org/10.1007/s00268- 016- 3660- 5.
13. Kiewiet JJ, Leeuwenburgh MM, Bipat S, Bossuyt PM, Stoker J, Boermeester MA.A system­atic review and meta-analysis of diagnostic performance of imaging in acute cholecystitis. Radiology. 2012;264(3):708–20. https://doi.org/10.1148/radiol.12111561.
14. Fuks D, Mouly C, Robert B, Hajji H, Yzet T, Regimbeau JM. Acute cholecystitis: preopera­tive CT can help the surgeon consider conversion from laparoscopic to open cholecystectomy. Radiology. 2012;263(1):128–38. https://doi.org/10.1148/radiol.12110460.
15. Bates DD, LeBedis CA, Soto JA, Gupta A. Use of magnetic resonance in pancreaticobiliary emergencies. Magn Reson Imaging Clin N Am. 2016;24(2):433–48. https://doi.org/10.1016/j.
mric.2015.11.010.
16. Watanabe Y, Nagayama M, Okumura A, Amoh Y, Katsube T, Suga T, Koyama S, Nakatani K, Dodo Y.MR imaging of acute biliary disorders. Radiographics. 2007;27(2):477–95. https://
doi.org/10.1148/rg.272055148.
17. Pinto A, Reginelli A, Cagini L, Coppolino F, Stabile Ianora AA, Bracale R, Giganti M, Romano L. Accuracy of ultrasonography in the diagnosis of acute calculous cholecysti­tis: review of the literature. Crit Ultrasound J. 2013;5 Suppl 1(Suppl 1):S11. https://doi.
org/10.1186/2036- 7902- 5- S1- S11.
18. Changphaisarnkul P, Saengruang-Orn S, Boonya-Asadorn T.The diagnosis of acute chole­cystitis: sensitivity of sonography, cholescintigraphy and computed tomography. J Med Assoc Thail. 2015;98(8):812–9.
19. Paul Wright G, Stilwell K, Johnson J, Hefty MT, Chung MH. Predicting length of stay and conversion to open cholecystectomy for acute cholecystitis using the 2013 Tokyo guidelines in a US population. J Hepatobiliary Pancreat Sci. 2015;22(11):795–801. https://doi.org/10.1002/
jhbp.284.
65
66
https://t.me/medicina_free
20. Ambe PC, Christ H, Wassenberg D.Does the Tokyo guidelines predict the extent of gallblad­der inammation in patients with acute cholecystitis? A single center retrospective analysis. BMC Gastroenterol. 2015;15:142. https://doi.org/10.1186/s12876- 015- 0365- 4.
21. Yokoe M, Takada T, Hwang TL, Endo I, Akazawa K, Miura F, Mayumi T, Mori R, Chen MF, Jan YY, Ker CG, Wang HP, Itoi T, Gomi H, Kiriyama S, Wada K, Yamaue H, Miyazaki M, Yamamoto M. Descriptive review of acute cholecystitis: Japan-Taiwan collaborative epide­miological study. J Hepatobiliary Pancreat Sci. 2017;24(6):319–28. https://doi.org/10.1002/
jhbp.450.
22. Endo I, Takada T, Hwang TL, Akazawa K, Mori R, Miura F, Yokoe M, Itoi T, Gomi H, Chen MF, Jan YY, Ker CG, Wang HP, Kiriyama S, Wada K, Yamaue H, Miyazaki M, Yamamoto M. Optimal treatment strategy for acute cholecystitis based on predictive factors: Japan­Taiwan multicenter cohort study. J Hepatobiliary Pancreat Sci. 2017;24(6):346–61. https://doi.
org/10.1002/jhbp.456.
23. Cheng WC, Chiu YC, Chuang CH, Chen CY. Assessing clinical outcomes of patients with acute calculous cholecystitis in addition to the Tokyo grading: a retrospective study. Kaohsiung J Med Sci. 2014;30(9):459–65. https://doi.org/10.1016/j.kjms.2014.05.005.
24. Kamalapurkar D, Pang TC, Siriwardhane M, Hollands M, Johnston E, Pleass H, Richardson A, Lam VW.Index cholecystectomy in grade II and III acute calculous cholecystitis is feasible and safe. ANZ J Surg. 2015;85(11):854–9. https://doi.org/10.1111/ans.12986.
25. Amirthalingam V, Low JK, Woon W, Shelat V.Tokyo guidelines 2013 may be too restrictive and patients with moderate and severe acute cholecystitis can be managed by early cholecys­tectomy too. Surg Endosc. 2017;31(7):2892–900. https://doi.org/10.1007/s00464- 016- 5300- 4.
26. Csendes A, Burdiles P, Diaz JC, Maluenda F, Korn O, Vallejo E, Csendes P. Prevalence of common bile duct stones according to the increasing number of risk factors present. A prospective study employing routinely intraoperative cholangiography in 477 cases. Hepatogastroenterology. 1998;45(23):1415–21.
27. Ko CW, Lee SP.Epidemiology and natural history of common bile duct stones and predic­tion of disease. Gastrointest Endosc. 2002;56(6 Suppl):S165–9. https://doi.org/10.1067/
mge.2002.129005.
28. Ahn KS, Yoon YS, Han HS, Cho JY. Use of liver function tests as rst-line diagnostic tools for predicting common bile duct stones in acute cholecystitis patients. World J Surg. 2016;40(8):1925–31. https://doi.org/10.1007/s00268- 016- 3517- y.
29. Gurusamy KS, Giljaca V, Takwoingi Y, Higgie D, Poropat G, Štimac D, Davidson BR.Ultrasound versus liver function tests for diagnosis of common bile duct stones. Cochrane Database Syst Rev. 2015;2015(2):CD011548. https://doi.org/10.1002/14651858.CD011548.
30. Boys JA, Doorly MG, Zehetner J, Dhanireddy KK, Senagore AJ.Can ultrasound common bile duct diameter predict common bile duct stones in the setting of acute cholecystitis? Am J Surg. 2014;207(3):432–5; discussion 435. https://doi.org/10.1016/j.amjsurg.2013.10.014.
31. ASGE Standards of Practice Committee, Maple JT, Ben-Menachem T, Anderson MA, Appalaneni V, Banerjee S, Cash BD, Fisher L, Harrison ME, Fanelli RD, Fukami N, Ikenberry SO, Jain R, Khan K, Krinsky ML, Strohmeyer L, Dominitz JA.The role of endoscopy in the evaluation of suspected choledocholithiasis. Gastrointest Endosc. 2010;71(1):1–9. https://doi.
org/10.1016/j.gie.2009.09.041.
32. Barkun AN, Barkun JS, Fried GM, Ghitulescu G, Steinmetz O, Pham C, Meakins JL, Goresky CA.Useful predictors of bile duct stones in patients undergoing laparoscopic cho­lecystectomy. McGill Gallstone Treatment Group. Ann Surg. 1994;220(1):32–9. https://doi.
org/10.1097/00000658- 199407000- 00006.
33. Cronan JJ.US diagnosis of choledocholithiasis: a reappraisal. Radiology. 1986;161(1):133–4.
https://doi.org/10.1148/radiology.161.1.3532178.
34. Bose SM, Mazumdar A, Prakash VS, Kocher R, Katariya S, Pathak CM.Evaluation of the predictors of choledocholithiasis: comparative analysis of clinical, biochemical, radiologi­cal, radionuclear, and intraoperative parameters. Surg Today. 2001;31(2):117–22. https://doi.
org/10.1007/s005950170194.
S. Frassini et al.
Acute Cholecystitis andEmergency Common Bile Duct Exploration
https://t.me/medicina_free
35. Abboud PA, Malet PF, Berlin JA, Staroscik R, Cabana MD, Clarke JR, Shea JA, Schwartz JS, Williams SV.Predictors of common bile duct stones prior to cholecystectomy: a meta- analysis. Gastrointest Endosc. 1996;44(4):450–5. https://doi.org/10.1016/s0016- 5107(96)70098- 6.
36. Dasari BV, Tan CJ, Gurusamy KS, Martin DJ, Kirk G, McKie L, Diamond T, Taylor MA.Surgical versus endoscopic treatment of bile duct stones. Cochrane Database Syst Rev. 2013;2013(12):CD003327. https://doi.org/10.1002/14651858.CD003327.pub4.
37. Christensen M, Matzen P, Schulze S, Rosenberg J.Complications of ERCP: a prospective study. Gastrointest Endosc. 2004;60(5):721–31. https://doi.org/10.1016/s0016- 5107(04)02169- 8.
38. Wang B, Liu Z, Lü Y, Zhao S, Chen L. A meta-analysis of preoperative versus intraopera­tive endoscopic sphincterotomy in patients with gallbladder and suspected common bile duct stones. Zhonghua Yi Xue Za Zhi. 2015;95(18):1425–9.
39. De U. Evolution of cholecystectomy: a tribute to Carl August Langenbuch. Indian J Surg. 2004;66:97–100.
40. Schmidt M, Søndenaa K, Vetrhus M, Berhane T, Eide GE.Long-term follow-up of a random­ized controlled trial of observation versus surgery for acute cholecystitis: non-operative man­agement is an option in some patients. Scand J Gastroenterol. 2011;46(10):1257–62. https://
doi.org/10.3109/00365521.2011.598548.
41. Charlson ME, Carrozzino D, Guidi J, Patierno C. Charlson comorbidity index: a criti­cal review of clinimetric properties. Psychother Psychosom. 2022;91(1):8–35. https://doi.
org/10.1159/000521288.
42. Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA.New ICD-10 ver­sion of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol. 2004;57(12):1288–94. https://doi.org/10.1016/j.jclinepi.2004.03.012.
43. https://www.asahq.org/standards- and- guidelines/asa- physical- status- classication- system
44. Catena F, Ansaloni L, Bianchi E, Di Saverio S, Coccolini F, Vallicelli C, Lazzareschi D, Sartelli M, Amaduzzi A, Amaduzz A, Pinna AD.The ACTIVE (acute cholecystitis trial invasive ver­sus endoscopic) study: multicenter randomized, double-blind, controlled trial of laparoscopic versus open surgery for acute cholecystitis. Hepatogastroenterology. 2013;60(127):1552–6.
45. Johansson M, Thune A, Nelvin L, Stiernstam M, Westman B, Lundell L.Randomized clinical trial of open versus laparoscopic cholecystectomy in the treatment of acute cholecystitis. Br J Surg. 2005;92(1):44–9. https://doi.org/10.1002/bjs.4836.
46. Hussain A.Difcult laparoscopic cholecystectomy: current evidence and strategies of man­agement. Surg Laparosc Endosc Percutan Tech. 2011;21(4):211–7. https://doi.org/10.1097/
SLE.0b013e318220f1b1.
47. Coccolini F, Catena F, Pisano M, Gheza F, Fagiuoli S, Di Saverio S, Leandro G, Montori G, Ceresoli M, Corbella D, Sartelli M, Sugrue M, Ansaloni L.Open versus laparoscopic cholecystectomy in acute cholecystitis. Systematic review and meta-analysis. Int J Surg. 2015;18:196–204. https://doi.org/10.1016/j.ijsu.2015.04.083.
48. Pisano M, Ceresoli M, Cimbanassi S, Gurusamy K, Coccolini F, Borzellino G, Costa G, Allievi N, Amato B, Boerma D, Calcagno P, Campanati L, Campanile FC, Casati A, Chiara O, Crucitti A, di Saverio S, Filauro M, Gabrielli F, Guttadauro A, Kluger Y, Magnone S, Merli C, Poiasina E, Puzziello A, Sartelli M, Catena F, Ansaloni L. 2017 WSES and SICG guidelines on acute calculous cholecystitis in elderly population. World J Emerg Surg. 2019;14:10. https://
doi.org/10.1186/s13017- 019- 0224- 7.
49. Gutt CN, Encke J, Köninger J, Harnoss JC, Weigand K, Kipfmüller K, Schunter O, Götze T, Golling MT, Menges M, Klar E, Feilhauer K, Zoller WG, Ridwelski K, Ackmann S, Baron A, Schön MR, Seitz HK, Daniel D, Stremmel W, Büchler MW.Acute cholecystitis: early versus delayed cholecystectomy, a multicenter randomized trial (ACDC study, NCT00447304). Ann Surg. 2013;258(3):385–93. https://doi.org/10.1097/SLA.0b013e3182a1599b.
50. Pucher PH, Brunt LM, Davies N, Linsk A, Munshi A, Rodriguez HA, Fingerhut A, Fanelli RD, Asbun H, Aggarwal R, SAGES Safe Cholecystectomy Task Force. Outcome trends and safety measures after 30 years of laparoscopic cholecystectomy: a systematic review and pooled data analysis. Surg Endosc. 2018;32(5):2175–83. https://doi.org/10.1007/s00464- 017- 5974- 2.
67
68
https://t.me/medicina_free
51. van Dijk AH, de Reuver PR, Tasma TN, van Dieren S, Hugh TJ, Boermeester MA.Systematic review of antibiotic treatment for acute calculous cholecystitis. Br J Surg. 2016;103(7):797–811.
https://doi.org/10.1002/bjs.10146.
52. Loozen CS, van Santvoort HC, van Duijvendijk P, Besselink MG, Gouma DJ, Nieuwenhuijzen GA, Kelder JC, Donkervoort SC, van Geloven AA, Kruyt PM, Roos D, Kortram K, Kornmann VN, Pronk A, van der Peet DL, Crolla RM, van Ramshorst B, Bollen TL, Boerma D. Laparoscopic cholecystectomy versus percutaneous catheter drainage for acute cholecystitis in high risk patients (CHOCOLATE): multicentre randomised clinical trial. BMJ. 2018;363:k3965. https://doi.org/10.1136/bmj.k3965.
53. Teoh AYB, Kitano M, Itoi T, Pérez-Miranda M, Ogura T, Chan SM, Serna-Higuera C, Omoto S, Torres-Yuste R, Tsuichiya T, Wong KT, Leung CH, Chiu PWY, Ng EKW, Lau JYW. Endosonography-guided gallbladder drainage versus percutaneous cholecystostomy in very high-risk surgical patients with acute cholecystitis: an international randomised multicen­tre controlled superiority trial (DRAC 1). Gut. 2020;69(6):1085–91. https://doi.org/10.1136/
gutjnl- 2019- 319996.
54. Sartelli M, Catena F, Ansaloni L, Coccolini F, Corbella D, Moore EE, Malangoni M, Velmahos G, Coimbra R, Koike K, Leppaniemi A, Bif W, Balogh Z, Bendinelli C, Gupta S, Kluger Y, Agresta F, Di Saverio S, Tugnoli G, Jovine E, Ordonez CA, Whelan JF, Fraga GP, Gomes CA, Pereira GA, Yuan KC, Bala M, Peev MP, Ben-Ishay O, Cui Y, Marwah S, Zachariah S, Wani I, Rangarajan M, Sakakushev B, Kong V, Ahmed A, Abbas A, Gonsaga RA, Guercioni G, Vettoretto N, Poiasina E, Díaz-Nieto R, Massalou D, Skrovina M, Gerych I, Augustin G, Kenig J, Khokha V, Tranà C, Kok KY, Mere AC, Lee JG, Hong SK, Lohse HA, Ghnnam W, Verni A, Lohsiriwat V, Siribumrungwong B, El Zalabany T, Tavares A, Baiocchi G, Das K, Jarry J, Zida M, Sato N, Murata K, Shoko T, Irahara T, Hamedelneel AO, Naidoo N, Adesunkanmi AR, Kobe Y, Ishii W, Oka K, Izawa Y, Hamid H, Khan I, Attri A, Sharma R, Sanjuan J, Badiel M, Barnabé R.Complicated intra-abdominal infections worldwide: the denitive data of the CIAOW study. World J Emerg Surg. 2014;9:37. https://doi.org/10.1186/1749- 7922- 9- 37.
S. Frassini et al.
Acute Colonic Diverticulitis
https://t.me/medicina_free
DarioTartaglia, FedericoCoccolini, AlessioMazzoni, ValerioGenovese, CamillaCremonini, EnricoCicuttin, andMassimoChiarugi
1 Percutaneous Drainage
Diverticulitis may occur with a pericolic or distant abscess in the pelvis: pericolic in 1B and pelvic distant from the colon in grade 2 according to Wasvary’s modied Hinchey’s classication [1]. The size of the abscess is the mainstream for proper treatment. The intravenous administration of large-spectrum antibiotics could be associated with the need to place percutaneous drainage, mainly in case of larger abscesses. The exact size cutoff in which one should apply for percutaneous drain­age has been a topic of debate for a long time, and nowadays, we still do not have a denitive answer. Since the early 2000s, the cutoff value diameter for amenability of the percutaneous abscess has progressively been reduced from 5 to 3cm [2, 3]. Abscesses under 3cm can be treated with IV, broad-spectrum antibiotics that cover Gram-negative and anaerobic bacteria. This medical approach could lead to a reso­lution in more than 80% of cases.
On the other hand, larger abscesses might be evacuated with US- or CT-guided percutaneous drainage (Figs.1 and 2). The choice to use US or CT as guidance depends on the abscess location: for instance, supercial ones could be easily chased by ultrasound. Therefore, CT scan represents the preferred method of evacu­ation [4]. However, this procedure is not free of risks: it has been shown that it is
D. Tartaglia (*) Emergency Surgery Unit and Trauma Center, University Hospital of Pisa, Pisa, Italy
Emergency Surgery Unit and Trauma Center, Cisanello Hospital, University of Pisa, Pisa, Italy e-mail: dario.tartaglia@unipi.it
F. Coccolini · A. Mazzoni · V. Genovese · C. Cremonini · E. Cicuttin · M. Chiarugi Emergency Surgery Unit and Trauma Center, University Hospital of Pisa, Pisa, Italy e-mail: federico.coccolini@unipi.it; massimo.chiarugi@unipi.it
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023 F. Coccolini et al. (eds.), Mini-invasive Approach in Acute Care Surgery, Hot Topics in Acute Care Surgery and Trauma,
https://doi.org/10.1007/978-3-031-39001-2_7
69
70
https://t.me/medicina_free
Fig. 1 A CT scan with contrast showing a large pelvic collections along the left paracolic gutter
Fig. 2 The pericolic abscess treated with a percutaneous “pig-tail” drain
D. Tartaglia et al.
related to 3% of complications, mainly constituted by visceral injuries rather than vascular ones.
Furthermore, it has been established that 57% of patients develop a stulous communication to the colon, subsequently to drain placement. Moreover, these patients had longer procedure times and larger abscess sizes. Conversely, female sex
Acute Colonic Diverticulitis
https://t.me/medicina_free
71
ab
Fig. 3 A 10cm pelvic abscess with an air level inside. (a, b) The abscess treated with a percutane- ous drain. For the presence of enteric material from the drain and the worsening of the patient’s clinical condition, a sigmoid resection was performed
and higher BMI may represent protective factors against the development of intes­tinal stulous communications [5].
The more the diameter increases, the higher is the risk of failure to control source infection in the percutaneous draining [6]. The presence of signicant comorbidi­ties, ASA (American Society of Anesthesiologists) score 4, elevated values of Charlson Comorbidity Index, and immunosuppression state represent other factors of risk of PCD failure [7, 8].
The recurrence rate after percutaneous drainage is about 25% [3]. Also, in these cases, abscesses larger than 5cm have an increased risk of recurrence [9].
Although the best treatment for larger abscesses is still not dened, we can assume that PCD must be almost always considered as the rst choice in non­peritonitis patients. In fact, acute surgery is related to a high rate of postoperative complications, permanent stoma, and short-term mortality (up to 12%).
Surgery is mandatory in case of PCD failure, a patient’s clinical worsening, and hemodynamical instability. A cutoff size of 5cm is predictive for the need for emer­gency surgery within 30days from the presentation (Fig.3) [10].
In their retrospective study on 105 patients undergoing CT-guided abscess drain­age, Raman etal. showed that 57% of patients presented a post-procedural stula. An 85% required surgical intervention, 83% of them with minimally invasive sur­gery. Interestingly, they found that men’s gender, lower BMIs, current tobacco users, higher ASA class, and larger abscess on initial presentation were related to stulous communication [11].
In conclusion, PCD could be a valuable tool in patients with diverticular abscess without signs of peritonitis. However, it might not be resolutive in larger abscesses and clinically compromised cases. Therefore, if the procedure fails, surgery must be advocated.
72
https://t.me/medicina_free
D. Tartaglia et al.
2 Laparoscopic Peritoneal Lavage
It has been widely described that laparoscopic peritoneal lavage has represented a potentially viable option for patients with purulent diverticulitis. By itself, the pro­cedure presents quite simple steps: placement of three ports, complete evacuation of the purulent collection, accurate visualization of the descending colon and sigma, execution of a hydropneumatic or methylene bleu test to rule out eventual visceral discontinuity, and nally putting some drains in situ. In the 1990s, several retrospec­tive studies showed very promising results that started a “hot” debate about the efcacy of this procedure in the treatment of peritonitis due to acute perforated diverticulitis. The discussion is heavily still going on [1214]. These rst studies reported very low rates of morbidity (0–4%), mortality (<2%), reoperation (2–7%), and diverticulitis recurrence (0–5%) during 12- to 48-month follow-up. As a result, the conclusions were very optimistic: the laparoscopic peritoneal lavage was con­sidered a safe and effective alternative to traditional surgical resection allowing to avoid elective colon resection in most cases [14]. However, during the second decade of this century, the scientic community raised a need to clarify the real benet deriving from laparoscopic peritoneal lavage. Thus, three randomized stud­ies from northern Europe were conducted: LADIEs, SCANDIV, and DILALA trials [1517]. The rst one in chronological order, the LADIEs with the LOLA arm, was prematurely interrupted because of an exceedingly high rate of complications in laparoscopic lavage [15]. The Scandinavian SCANDIV study reported a higher complication rate, short-term morbidity, and mortality in laparoscopic lavage, even though long-term follow-up showed no differences in severe complications [18]. Furthermore, the authors identied that recurrence of diverticulitis after laparo­scopic lavage was more common (21% vs. 4%), often leading to sigmoid resection (30%). The authors agreed that a higher resection rate must be weighed against the lower stoma prevalence in laparoscopic lavage, encouraging to take “shared” deci­sions, considering both short-term and long-term consequences. On the other hand, the DILALA trial reported better results for laparoscopic lavage, identifying shorter operative time, and hospital stay with no differences in terms of morbidity and mor­tality [17]. At the 2-year follow-up, the laparoscopic lavage was associated with a 45% reduced risk of undergoing operations than Hartmann’s. In the study by Kohl etal., the authors considered the laparoscopic lavage a better option for perforated diverticulitis with purulent peritonitis than open resection and colostomy [19]. However, an important criticism merging from the literature versus these encourag­ing results was represented by the very limited number of patients per arm enrolled in the DILALA: 39in the lavage group and 36in Hartmann’s procedure [20]. A multicentric prospective international study was conducted in 2018: the LLO Study, which included 231 patients affected by purulent peritonitis caused by acute diver­ticulitis. Among 212 patients who underwent lavage, the postoperative morbidity rate was 33%, the mortality rate was 2%, and the readmission rate was 10%. Overall, the technique was successful in 172 patients (81%): there were no signs of sepsis and no need for further surgery during the hospital stay and 60days after discharge.
Acute Colonic Diverticulitis
https://t.me/medicina_free
73
Nevertheless, 46 episodes (26.7%) of acute diverticulitis were recorded during the 11-month follow-up [21].
Several meta-analyses have been performed with different results [2233]. The difference in the results was due to the variability of the considered studies, the type of the analysis, and the focused outcomes analyzed. Some reviews concluded that laparoscopic lavage does not represent a safe approach for purulent diverticular peritonitis because of the high rate of reoperations (up to 30%), higher rate of post­operative intra-abdominal abscesses, and the relevant risk of not recognizing a car­cinoma in almost 10% of patients [24, 25, 27, 29, 34, 35]. Other reviews gave more prudent conclusions, reporting that laparoscopic lavage can be comparable to sig­moid resection in terms of mortality. At the same time, it is related to a signicantly higher rate of reoperations and intra-abdominal abscesses [23, 26, 33]. Conversely, other meta-analyses supported the use of laparoscopic lavage, stating that the pro­cedure may be an effective and safe option for the treatment of patients with puru­lent diverticular peritonitis; in fact, the lavage is associated with a lower risk of reoperations within the rst 12months after index surgery, lower hospital costs, and comparable morbidity and mortality than resections [22, 30, 31].
An important point in favor of the laparoscopic lavage is the reduced risk of colostomy at 1- and 2-year follow-up, when the procedure is effective [19, 36]. Schultz etal. described a signicantly lower stoma rate in the lavage group than resection (14% vs. 42%) at the 1-year follow-up of the SCANDIV study. However, the quality of life did not differ between groups, as laparoscopic lavage was associ­ated with deeper surgical-site infections (32% vs.13%) and more unplanned reop­erations (27% vs. 10%) [36]. Kohl etal., instead, reported better results in their 2-year results of the randomized clinical trial DILALA.The lavage group had a 45% reduced risk of undergoing one or more operations, fewer operation rates than Hartmann’s group, and a more reduced stoma rate (7% vs. 23%). In addition, the authors did not nd signicant differences in the mean number of readmissions and mortality [19].
Very few studies focused on comparing laparoscopic peritoneal lavage versus laparoscopic sigmoidectomy in complicated acute diverticulitis. A multicentric study by Catry etal. enrolled 40 patients with purulent diverticular peritonitis and compared 15 laparoscopic peritoneal lavages versus 25 sigmoidectomies. In the lat­ter group, only four were treated with a laparoscopic approach. 40% of laparoscopic lavage patients required reoperation for peritonitis (26.6%), intra-abdominal bleed­ing (13.3%), intra-abdominal abscess (7%), ileus (7%), and wound infections (7%). For these reasons, the authors concluded that laparoscopic lavage is associated with a high risk of failure in daily practice. Consequently, laparoscopic sigmoidectomy should be the primary option for treating purulent diverticular peritonitis [37]. In a multicenter study led by our Institution, 66 patients with a pelvic abscess not ame­nable to conservative management or with purulent diverticular peritonitis were enrolled: 28 (42%) underwent laparoscopic lavage and 38 (58%) underwent laparo­scopic sigmoidectomy. The authors found that the failure to achieve source control and the need to return to the operating room were more frequent in laparoscopic lavage (29.6% vs. 2.6% and 18.5% vs. 0, respectively). Furthermore, diverticular
74
https://t.me/medicina_free
D. Tartaglia et al.
recurrence was signicantly higher in the lavage group (27.3% vs. 0%). As a result, the authors concluded that laparoscopic lavage for perforated diverticulitis carries a high risk of failure in daily practice [38].
Laparoscopic lavage is cheaper than colonic resection. In the Swedish DILALA trial, clinical effectiveness and resource use were derived from the 43 patients ran­domized in the laparoscopic lavage group and the remaining 40 treated with Hartmann’s procedure. In the laparoscopic lavage group, the authors found a mean discount per patient of almost €9000 at the short-term analysis (rst 12months) and almost €19,794 at the long-term analysis. So far, they concluded that the signicant cost reduction, the safeness, and the efcacy of laparoscopic lavage make the pro­cedure eligible for a routinary use for the treatment of complicated diverticular peritonitis [39]. Quite similar results were obtained by Vennixet al. in their eco­nomic evaluation of the randomized LOLA (LaparOscopicLAvage) arm of the Ladies trial. They demonstrated that total medical costs for lavage were lower (almost €3500) at 12months, although surgical interventions may increase costs. The same was for the long-term results, where lavage was associated with a reduced cost of almost € 6377. It must be said that stoma reversal operations can also get costs increased in the Hartmann’s procedure group. However, considering the fail­ure in carrying on the LOLA arm in the LADIES study due to an unacceptable too much high rate of postoperative complications, the authors were more prudent in exalting the lavage.
The positions about laparoscopic lavage from the major international surgical societies’ guidelines are very different. The recent guidelines from the World Society of Emergency Surgery state: We suggest performing laparoscopic perito-
neal lavage and drainage only in very selected patients with generalized peritonitis. It is not considered as the rst line treatment in patients with peritonitis from acute colonic diverticulitis, notwithstanding weak recommendation [40]. The European
Association for Endoscopic Surgery (EAES) and Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) guidelines on acute diverticu­litis management recommend that: Lavage should be considered in selected Hinchey
III patients by surgeons with appropriate expertise and the ability to closely watch for and manage complications; the lower stoma rate should be weighed against the higher risk of complications and re-intervention. Also, in this case, recommenda-
tions were weak [41]. Recently, the European Society of Coloproctology guidelines stated more straightforwardly: Laparoscopic lavage is feasible in selected patients with Hinchey III peritonitis. Alternatively, resection is recommended [42]. The 2020 American Society of Colon and Rectal Surgeons Guidelines for the management of left-sided colonic diverticulitis recommends colectomy for both feculent and puru­lent peritonitis, stating that In patients with purulent peritonitis, colectomy is pre-
ferred over laparoscopic lavage. Laparoscopic lavage is associated with higher rates of secondary intervention in comparison with colectomy [43]. Interestingly,
the Japanese guidelines for diverticular disease management did neither consider the laparoscopic lavage [44].
Briey, we could conclude that laparoscopic peritoneal lavage is feasible in patients with purulent diverticulitis. Still, it should be reserved only in very selected